119 related articles for article (PubMed ID: 21124844)
1. Frequency of HIV-1 viral load monitoring of patients initially successfully treated with combination antiretroviral therapy.
Romih V; Zidovec Lepej S; Gedike K; Lukas D; Begovac J
PLoS One; 2010 Nov; 5(11):e15051. PubMed ID: 21124844
[TBL] [Abstract][Full Text] [Related]
2. Regional differences in rates of HIV-1 viral load monitoring in Canada: Insights and implications for antiretroviral care in high income countries.
Raboud JM; Loutfy MR; Su D; Bayoumi AM; Klein MB; Cooper C; Machouf N; Rourke S; Walmsley S; Rachlis A; Harrigan PR; Smieja M; Tsoukas C; Montaner JS; Hogg RS;
BMC Infect Dis; 2010 Feb; 10():40. PubMed ID: 20184766
[TBL] [Abstract][Full Text] [Related]
3. A Markov model for the effects of virological failure on HIV/AIDS progression in tuberculosis co-infected patients receiving antiretroviral therapy in a rural clinic in northern South Africa.
Shoko C; Chikobvu D; Bessong PO
S Afr Med J; 2020 Mar; 110(4):313-319. PubMed ID: 32657744
[TBL] [Abstract][Full Text] [Related]
4. HIV Viral Load Monitoring Frequency and Risk of Treatment Failure among Immunologically Stable HIV-Infected Patients Prescribed Combination Antiretroviral Therapy.
Young B; Hart RL; Buchacz K; Scott M; Palella F; Brooks JT;
J Int Assoc Provid AIDS Care; 2015; 14(6):536-43. PubMed ID: 26293905
[TBL] [Abstract][Full Text] [Related]
5. Impact of polymorphisms in the HCP5 and HLA-C, and ZNRD1 genes on HIV viral load.
Thørner LW; Erikstrup C; Harritshøj LH; Larsen MH; Kronborg G; Pedersen C; Larsen CS; Pedersen G; Gerstoft J; Obel N; Ullum H
Infect Genet Evol; 2016 Jul; 41():185-190. PubMed ID: 27083073
[TBL] [Abstract][Full Text] [Related]
6. Prognosis of patients treated with cART from 36 months after initiation, according to current and previous CD4 cell count and plasma HIV-1 RNA measurements.
; Lanoy E; May M; Mocroft A; Phillip A; Justice A; Chêne G; Furrer H; Sterling T; Monforte AD; Force L; Gill J; Harris R; Hogg RS; Rockstroh J; Saag M; Khaykin P; de Wolf F; Sterne JA; Costagliola D
AIDS; 2009 Oct; 23(16):2199-208. PubMed ID: 19779320
[TBL] [Abstract][Full Text] [Related]
7. Trends in CD4 counts in HIV-infected patients with HIV viral load monitoring while on combination antiretroviral treatment: results from The TREAT Asia HIV Observational Database.
Zhou J; Sirisanthana T; Kiertiburanakul S; Chen YM; Han N; Lim PL; Kumarasamy N; Choi JY; Merati TP; Yunihastuti E; Oka S; Kamarulzaman A; Phanuphak P; Lee CK; Li PC; Pujari S; Saphonn V; Law MG
BMC Infect Dis; 2010 Dec; 10():361. PubMed ID: 21182796
[TBL] [Abstract][Full Text] [Related]
8. Elevated CD8 T-cell counts and virological failure in HIV-infected patients after combination antiretroviral therapy.
Ku NS; Jiamsakul A; Ng OT; Yunihastuti E; Cuong DD; Lee MP; Sim BLH; Phanuphak P; Wong WW; Kamarulzaman A; Zhang F; Pujari S; Chaiwarith R; Oka S; Mustafa M; Kumarasamy N; Van Nguyen K; Ditangco R; Kiertiburanakul S; Merati TP; Durier N; Choi JY;
Medicine (Baltimore); 2016 Aug; 95(32):e4570. PubMed ID: 27512885
[TBL] [Abstract][Full Text] [Related]
9. A Decade of Combination Antiretroviral Treatment in Asia: The TREAT Asia HIV Observational Database Cohort.
AIDS Res Hum Retroviruses; 2016 Aug; 32(8):772-81. PubMed ID: 27030657
[TBL] [Abstract][Full Text] [Related]
10. Changes over time in risk of initial virological failure of combination antiretroviral therapy: a multicohort analysis, 1996 to 2002.
Lampe FC; Gatell JM; Staszewski S; Johnson MA; Pradier C; Gill MJ; de Lazzari E; Dauer B; Youle M; Fontas E; Krentz HB; Phillips AN
Arch Intern Med; 2006 Mar; 166(5):521-8. PubMed ID: 16534038
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and effect of pre-treatment drug resistance on the virological response to antiretroviral treatment initiated in HIV-infected children - a EuroCoord-CHAIN-EPPICC joint project.
Ngo-Giang-Huong N; Wittkop L; Judd A; Reiss P; Goetghebuer T; Duiculescu D; Noguera-Julian A; Marczynska M; Giacquinto C; Ene L; Ramos JT; Cellerai C; Klimkait T; Brichard B; Valerius N; Sabin C; Teira R; Obel N; Stephan C; de Wit S; Thorne C; Gibb D; Schwimmer C; Campbell MA; Pillay D; Lallemant M;
BMC Infect Dis; 2016 Nov; 16(1):654. PubMed ID: 27825316
[TBL] [Abstract][Full Text] [Related]
12. Toxicity-related antiretroviral drug treatment modifications in individuals starting therapy: a cohort analysis of time patterns, sex, and other risk factors.
Perović Mihanović M; Haque NS; Rutherford GW; Zekan Š; Begovac J
Med Sci Monit; 2013 Jun; 19():483-92. PubMed ID: 23787803
[TBL] [Abstract][Full Text] [Related]
13. Meeting the WHO 90% target: antiretroviral treatment efficacy in Poland is associated with baseline clinical patient characteristics.
Parczewski M; Siwak E; Leszczyszyn-Pynka M; Cielniak I; Burkacka E; Pulik P; Witor A; Muller K; Zasik E; Grzeszczuk A; Jankowska M; Lemańska M; Olczak A; Grąbczewska E; Szymczak A; Gąsiorowski J; Szetela B; Bociąga-Jasik M; Skwara P; Witak-Jędra M; Jabłonowska E; Wójcik-Cichy K; Kamerys J; Janczarek M; Krankowska D; Mikuła T; Kozieł K; Bielec D; Stempkowska J; Kocbach A; Błudzin W; Horban A
J Int AIDS Soc; 2017 Jul; 20(1):21847. PubMed ID: 28715160
[TBL] [Abstract][Full Text] [Related]
14. CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy.
Wolbers M; Battegay M; Hirschel B; Furrer H; Cavassini M; Hasse B; Vernazza PL; Bernasconi E; Kaufmann G; Bucher HC;
Antivir Ther; 2007; 12(6):889-97. PubMed ID: 17926643
[TBL] [Abstract][Full Text] [Related]
15. Factors Associated with Low-Level Viraemia and Virological Failure: Results from the Austrian HIV Cohort Study.
Leierer G; Grabmeier-Pfistershammer K; Steuer A; Geit M; Sarcletti M; Haas B; Kanatschnig M; Rappold M; Zangerle R; Ledergerber B; Taylor N;
PLoS One; 2015; 10(11):e0142923. PubMed ID: 26566025
[TBL] [Abstract][Full Text] [Related]
16. Effect of transient antiretroviral treatment during acute HIV infection: comparison of the Quest trial results with CASCADE natural history study.
Lampe FC; Porter K; Kaldor J; Law M; Kinloch-de Loes S; Phillips AN;
Antivir Ther; 2007; 12(2):189-93. PubMed ID: 17503661
[TBL] [Abstract][Full Text] [Related]
17. When patients fail UNAIDS' last 90 - the "failure cascade" beyond 90-90-90 in rural Lesotho, Southern Africa: a
Labhardt ND; Ringera I; Lejone TI; Cheleboi M; Wagner S; Muhairwe J; Klimkait T
J Int AIDS Soc; 2017 Jul; 20(1):21803. PubMed ID: 28777506
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 RNA viral load monitoring in HIV-infected drug users on antiretroviral therapy: relationship with outpatient care patterns.
Laine C; Zhang D; Hauck WW; Turner BJ
J Acquir Immune Defic Syndr; 2002 Mar; 29(3):270-4. PubMed ID: 11873076
[TBL] [Abstract][Full Text] [Related]
19. A prognostic model for estimating the time to virologic failure in HIV-1 infected patients undergoing a new combination antiretroviral therapy regimen.
Prosperi MC; Di Giambenedetto S; Fanti I; Meini G; Bruzzone B; Callegaro A; Penco G; Bagnarelli P; Micheli V; Paolini E; Di Biagio A; Ghisetti V; Di Pietro M; Zazzi M; De Luca A;
BMC Med Inform Decis Mak; 2011 Jun; 11():40. PubMed ID: 21672248
[TBL] [Abstract][Full Text] [Related]
20. Durability of lopinavir/ritonavir monotherapy in individuals with viral load ≤50 copies/ml in an observational setting.
d'Arminio Monforte A; Gianotti N; Cozzi-Lepri A; Pinnetti C; Andreoni M; di Perri G; Galli M; Poli A; Costantini A; Orofino G; Maggiolo F; Mazzarello G; Celesia BM; Luciani F; Lazzarin A; Sighinolfi L; Rizzardini G; Bonfanti P; Perno CF; Antinori A;
Antivir Ther; 2014; 19(3):319-24. PubMed ID: 24036891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
